[HTML][HTML] Anti-SARS-CoV-2 antibody testing: role and indications
S Mink, P Fraunberger - Journal of Clinical Medicine, 2023 - mdpi.com
Since the onset of the COVID-19 pandemic in March 2020, over 769 million confirmed
COVID-19 cases, including close to 7 million COVID-19-related deaths, have been reported …
COVID-19 cases, including close to 7 million COVID-19-related deaths, have been reported …
Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study
Abstract Background and Aim Understanding the prevalence and impact of SARS‐CoV‐2
variants has assumed paramount importance. This study statistically analyzed to effectively …
variants has assumed paramount importance. This study statistically analyzed to effectively …
COVID-19 vaccine acceptance and its association with knowledge and attitude among patients with chronic diseases in Ethiopia
TD Tsega, AM Kebede, TM Dessie… - Human Vaccines & …, 2024 - Taylor & Francis
ABSTRACT COVID-19 vaccine acceptance is crucial for patients with chronic diseases, but
previous studies in Ethiopia have yielded inconsistent and inconclusive findings. To fill this …
previous studies in Ethiopia have yielded inconsistent and inconclusive findings. To fill this …
Association of pre-existing depression and anxiety with Omicron variant infection
H Yang, L Yang, W Chen, Y Zeng, Y Zhang… - Molecular …, 2024 - nature.com
Pre-existing psychiatric disorders were linked to an increased susceptibility to COVID-19
during the initial outbreak of the pandemic, while evidence during Omicron prevalence is …
during the initial outbreak of the pandemic, while evidence during Omicron prevalence is …
[HTML][HTML] Country-specific determinants for COVID-19 case fatality rate and response strategies from a global perspective: an interpretable machine learning framework
C Zhou, ÅM Wheelock, C Zhang, J Ma, Z Li… - Population Health …, 2024 - Springer
Background There are significant geographic inequities in COVID-19 case fatality rates
(CFRs), and comprehensive understanding its country-level determinants in a global …
(CFRs), and comprehensive understanding its country-level determinants in a global …
[HTML][HTML] Estimation of standardized real-time fatality rate for ongoing epidemics
Y Qu, CY Lee - Plos one, 2024 - journals.plos.org
Background The fatality rate is a crucial metric for guiding public health policies during an
ongoing epidemic. For COVID-19, the age structure of the confirmed cases changes over …
ongoing epidemic. For COVID-19, the age structure of the confirmed cases changes over …
Changing patterns of bacterial profile and antimicrobial resistance in high-risk patients during the COVID-19 pandemic at a tertiary oncology hospital
RM Abdel-Hamid, HA El-Mahallawy, RM Allam… - Archives of …, 2024 - Springer
The widespread evolution of phenotypic resistance in clinical isolates over the years,
coupled with the COVID-19 pandemic onset, has exacerbated the global challenge of …
coupled with the COVID-19 pandemic onset, has exacerbated the global challenge of …
Comparative Analysis of COVID-19 Outcomes in Type 1 and Type 2 Diabetes: A Three-Year Retrospective Study
F Cioca, R Timar, F Ignuta, A Vlad, F Bratosin, O Rosca… - Medicina, 2024 - mdpi.com
Background and Objectives: This comprehensive retrospective study assesses COVID-19
outcomes in type 1 (T1D) and type 2 diabetes (T2D) patients across three years, focusing on …
outcomes in type 1 (T1D) and type 2 diabetes (T2D) patients across three years, focusing on …
[HTML][HTML] Effectiveness of early pharmaceutical interventions in symptomatic COVID-19 patients: A randomized clinical trial
S Azhar, J Akram, W Latif, NC Ibanez… - Pakistan Journal of …, 2024 - ncbi.nlm.nih.gov
Objective: We assessed the effectiveness of oral Hydroxychloroquine (HC), Azithromycin
(AZ) and Oseltamivir (OS), alone or combined, among patients hospitalized with mildly …
(AZ) and Oseltamivir (OS), alone or combined, among patients hospitalized with mildly …
[HTML][HTML] Health Consequences Among COVID-19 Convalescent Patients 30 Months Post-Infection in China
Y Yin, YB Guo, M Xiao, Q Chen, P Long, X Wang… - Zoonoses, 2024 - scienceopen.com
Objective: The health consequences among COVID-19 convalescent patients 30 months
post-infection were described and the potential risk factors were determined. Methods: In …
post-infection were described and the potential risk factors were determined. Methods: In …